Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 088127
Company: WATSON LABS
Company: WATSON LABS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
HYDROFLUMETHIAZIDE AND RESERPINE | HYDROFLUMETHIAZIDE; RESERPINE | 25MG;0.125MG | TABLET;ORAL | Discontinued | None | No | No |